PEAK BIO

YTD

ALL

Why Robinhood?

You can watch PEAK BIO and buy or sell other stocks, ETFs, and their options commission-free!

About PKBO

Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease.

CEO

Stephen J. LaMond, PhD, MBA

CEOStephen J. LaMond, PhD, MBA

Employees

—

Employees—

Headquarters

Pleasanton, California

HeadquartersPleasanton, California

Founded

2016

Founded2016

Employees

—

Employees—

PKBO Key Statistics

Market cap

520.31K

Market cap520.31K

Price-Earnings ratio

-0.14

Price-Earnings ratio-0.14

Dividend yield

—

Dividend yield—

Average volume

6.61K

Average volume6.61K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.2646

52 Week high$0.2646

52 Week low

$0.002

52 Week low$0.002

People also own

Based on the portfolios of people who own PKBO. This list is generated using Robinhood data, and it’s not a recommendation.

AMTD Digital Inc. America…